Induction Therapy in Simultaneous Pancreas-Kidney Transplantation: Thymoglobulin Versus Basiliximab

2015 ◽  
Vol 47 (1) ◽  
pp. 120-122 ◽  
Author(s):  
I. Fernández-Burgos ◽  
M.C. Montiel Casado ◽  
J.A. Pérez-Daga ◽  
J.M. Aranda-Narváez ◽  
B. Sánchez-Pérez ◽  
...  
Keyword(s):  
Kidney Transplantation ◽  
Induction Therapy ◽  
Pancreas Kidney Transplantation ◽  
Simultaneous Pancreas Kidney ◽  
Simultaneous Pancreas Kidney Transplantation

scholarly journals Impact of Early Pancreatic Graft Loss on Outcome after Simultaneous Pancreas–Kidney Transplantation (SPKT)—A Landmark Analysis

2021 ◽  
Vol 10 (15) ◽  
pp. 3237
Author(s):  
Lukas Johannes Lehner ◽  
Robert Öllinger ◽  
Brigitta Globke ◽  
Marcel G. Naik ◽  
Klemens Budde ◽  
...  
Keyword(s):  
Kidney Transplantation ◽  
Graft Survival ◽  
Graft Loss ◽  
Type I ◽  
Kidney Graft ◽  
Landmark Analysis ◽  
Pancreas Kidney Transplantation ◽  
Simultaneous Pancreas Kidney ◽  
Simultaneous Pancreas Kidney Transplantation ◽  
Pancreas Graft

(1) Background: Simultaneous pancreas–kidney transplantation (SPKT) is a standard therapeutic option for patients with diabetes mellitus type I and kidney failure. Early pancreas allograft failure is a complication potentially associated with worse outcomes. (2) Methods: We performed a landmark analysis to assess the impact of early pancreas graft loss within 3 months on mortality and kidney graft survival over 10 years. This retrospective single-center study included 114 adult patients who underwent an SPKT between 2005 and 2018. (3) Results: Pancreas graft survival rate was 85.1% at 3 months. The main causes of early pancreas graft loss were thrombosis (6.1%), necrosis (2.6%), and pancreatitis (2.6%). Early pancreas graft loss was not associated with reduced patient survival (p = 0.168) or major adverse cerebral or cardiovascular events over 10 years (p = 0.741) compared to patients with functioning pancreas, after 3 months. Moreover, kidney graft function (p = 0.494) and survival (p = 0.461) were not significantly influenced by early pancreas graft loss. (4) Conclusion: In this study, using the landmark analysis technique, early pancreas graft loss within 3 months did not significantly impact patient or kidney graft survival over 10 years.

scholarly journals Impact ofde novodonor-specific anti-HLA antibodies on grafts outcomes in simultaneous pancreas-kidney transplantation

2015 ◽  
Vol 29 (2) ◽  
pp. 173-183 ◽  
Author(s):  
Jorge Malheiro ◽  
La Salete Martins ◽  
Sandra Tafulo ◽  
Leonídio Dias ◽  
Isabel Fonseca ◽  
...  
Keyword(s):  
Kidney Transplantation ◽  
Hla Antibodies ◽  
Pancreas Kidney Transplantation ◽  
Simultaneous Pancreas Kidney ◽  
Simultaneous Pancreas Kidney Transplantation

scholarly journals Experience with Simultaneous Pancreas-kidney Transplantation

1988 ◽  
Vol 208 (4) ◽  
pp. 475-483 ◽  
Author(s):  
HANS W. SOLLINGER ◽  
ROBERT J. STRATTA ◽  
ANTHONY M. DʼALESSANDRO ◽  
MUNCI KALAYOGLU ◽  
JOHN D. PIRSCH ◽  
...  
Keyword(s):  
Kidney Transplantation ◽  
Pancreas Kidney Transplantation ◽  
Simultaneous Pancreas Kidney ◽  
Simultaneous Pancreas Kidney Transplantation
Sign in / Sign up

Export Citation Format

Share Document